Australia's Recce Pharmaceutical hits over 2-yr high on $3.5 million R&D tax rebate

Recce Pharmaceuticals

14/01/2026 04:51

** Shares of Recce Pharmaceuticals RCE.AX rise 3% to A$0.69, their highest level since early Sept 2023

** Pharmaceutical co receives cash refund of A$5.3 million  ($3.55 million) research and development tax incentive rebate from the Australian Taxation Office

** Stock up 35.3% in 2025

($1 = 1.4932 Australian dollars)

 (Reporting by Jasmeen Ara Shaikh in Bengaluru)

 ((Jasmeenaraislam.Shaikh@thomsonreuters.com;))